[Federal Register: April 30, 1999 (Volume 64, Number 83)] [Notices] [Page 23342] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr30ap99-105] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel--National Cooperative Drug Discovery Groups--Opportunistic Infections. Date: June 4-5, 1999. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Gaithersburg, The Washington Room, 2 Montgomery Village Avenue, Gaithersburg, MD 20879. Contact Person: Vassil S. Georgiev, PhD, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Solar Building, Room 4C04, 6003 Executive Boulevard MSC 7610, Bethesda, MD 20892-7610, 301-496-8206. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Date: April 26, 1999. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy, National Institutes of Health. [FR Doc. 99-10923 Filed 4-29-99; 8:45 am] BILLING CODE 4140-01-M